390 related articles for article (PubMed ID: 16630581)
1. Absence of hearing loss in a mouse model for DFNA17 and MYH9-related disease: the use of public gene-targeted ES cell resources.
Parker LL; Gao J; Zuo J
Brain Res; 2006 May; 1091(1):235-42. PubMed ID: 16630581
[TBL] [Abstract][Full Text] [Related]
2. Targeted disruption of mouse ortholog of the human MYH9 responsible for macrothrombocytopenia with different organ involvement: hematological, nephrological, and otological studies of heterozygous KO mice.
Matsushita T; Hayashi H; Kunishima S; Hayashi M; Ikejiri M; Takeshita K; Yuzawa Y; Adachi T; Hirashima K; Sone M; Yamamoto K; Takagi A; Katsumi A; Kawai K; Nezu T; Takahashi M; Nakashima T; Naoe T; Kojima T; Saito H
Biochem Biophys Res Commun; 2004 Dec; 325(4):1163-71. PubMed ID: 15555549
[TBL] [Abstract][Full Text] [Related]
3. MYH9-siRNA and MYH9 mutant alleles: expression in cultured cell lines and their effects upon cell structure and function.
Li Y; Friedmann DR; Mhatre AN; Lalwani AK
Cell Motil Cytoskeleton; 2008 May; 65(5):393-405. PubMed ID: 18330899
[TBL] [Abstract][Full Text] [Related]
4. Progressive hearing loss in mice carrying a mutation in the p75 gene.
Sato T; Doi K; Taniguchi M; Yamashita T; Kubo T; Tohyama M
Brain Res; 2006 May; 1091(1):224-34. PubMed ID: 16564506
[TBL] [Abstract][Full Text] [Related]
5. Non-muscle myosin heavy chain IIA and IIB interact and co-localize in living cells: relevance for MYH9-related disease.
Marini M; Bruschi M; Pecci A; Romagnoli R; Musante L; Candiano G; Ghiggeri GM; Balduini C; Seri M; Ravazzolo R
Int J Mol Med; 2006 May; 17(5):729-36. PubMed ID: 16596254
[TBL] [Abstract][Full Text] [Related]
6. Auditory development in progressive motor neuronopathy mouse mutants.
Volkenstein S; Brors D; Hansen S; Berend A; Mlynski R; Aletsee C; Dazert S
Neurosci Lett; 2009 Nov; 465(1):45-9. PubMed ID: 19735697
[TBL] [Abstract][Full Text] [Related]
7. Perioperative management of MYH9 hereditary macrothrombocytopenia (Fechtner syndrome).
Selleng K; Lubenow LE; Greinacher A; Warkentin TE
Eur J Haematol; 2007 Sep; 79(3):263-8. PubMed ID: 17655694
[TBL] [Abstract][Full Text] [Related]
8. Analysis of clinical manifestations, mutant gene and encoded protein in two Chinese MYH9-related disease families.
Yi Y; Sen Zhang G; Xu M; San Ling Z; Ru Shao X; Zeng Li J; Ma J
Clin Chim Acta; 2006 Nov; 373(1-2):49-54. PubMed ID: 16806139
[TBL] [Abstract][Full Text] [Related]
9. MYH9-related platelet disorders.
Althaus K; Greinacher A
Semin Thromb Hemost; 2009 Mar; 35(2):189-203. PubMed ID: 19408192
[TBL] [Abstract][Full Text] [Related]
10. Identification of six novel MYH9 mutations and genotype-phenotype relationships in autosomal dominant macrothrombocytopenia with leukocyte inclusions.
Kunishima S; Matsushita T; Kojima T; Amemiya N; Choi YM; Hosaka N; Inoue M; Jung Y; Mamiya S; Matsumoto K; Miyajima Y; Zhang G; Ruan C; Saito K; Song KS; Yoon HJ; Kamiya T; Saito H
J Hum Genet; 2001; 46(12):722-9. PubMed ID: 11776386
[TBL] [Abstract][Full Text] [Related]
11. Cloning and developmental expression of nonmuscle myosin IIA (Myh9) in the mammalian inner ear.
Mhatre AN; Li J; Kim Y; Coling DE; Lalwani AK
J Neurosci Res; 2004 May; 76(3):296-305. PubMed ID: 15079858
[TBL] [Abstract][Full Text] [Related]
12. R705H mutation of MYH9 is associated with MYH9-related disease and not only with non-syndromic deafness DFNA17.
Verver E; Pecci A; De Rocco D; Ryhänen S; Barozzi S; Kunst H; Topsakal V; Savoia A
Clin Genet; 2015 Jul; 88(1):85-9. PubMed ID: 24890873
[TBL] [Abstract][Full Text] [Related]
13. [Autosomal dominant macrothrombocytopenia with leukocyte inclusion bodies and MYH9 disorders].
Kunishima S
Rinsho Byori; 2009 Apr; 57(4):365-70. PubMed ID: 19489439
[TBL] [Abstract][Full Text] [Related]
14. Identification of the first duplication in MYH9-related disease: a hot spot for unequal crossing-over within exon 24 of the MYH9 gene.
De Rocco D; Pujol-Moix N; Pecci A; Faletra F; Bozzi V; Balduini CL; Savoia A
Eur J Med Genet; 2009; 52(4):191-4. PubMed ID: 19450438
[TBL] [Abstract][Full Text] [Related]
15. Detection of unique neutrophil non-muscle myosin heavy chain-A localization by immunofluorescence analysis in MYH9 disorder presented with macrothrombocytopenia without leukocyte inclusions and deafness.
Kunishima S; Matsushita T; Shiratsuchi M; Ikuta T; Nishimura J; Hamaguchi M; Naoe T; Saito H
Eur J Haematol; 2005 Jan; 74(1):1-5. PubMed ID: 15613099
[TBL] [Abstract][Full Text] [Related]
16. Megakaryocytes of patients with MYH9-related thrombocytopenia present an altered proplatelet formation.
Pecci A; Malara A; Badalucco S; Bozzi V; Torti M; Balduini CL; Balduini A
Thromb Haemost; 2009 Jul; 102(1):90-6. PubMed ID: 19572073
[TBL] [Abstract][Full Text] [Related]
17. Cochlear implants for DFNA17 deafness.
Hildebrand MS; de Silva MG; Gardner RJ; Rose E; de Graaf CA; Bahlo M; Dahl HH
Laryngoscope; 2006 Dec; 116(12):2211-5. PubMed ID: 17146397
[TBL] [Abstract][Full Text] [Related]
18. Serotonin 2B receptor: upregulated with age and hearing loss in mouse auditory system.
Tadros SF; D'Souza M; Zettel ML; Zhu X; Lynch-Erhardt M; Frisina RD
Neurobiol Aging; 2007 Jul; 28(7):1112-23. PubMed ID: 16822592
[TBL] [Abstract][Full Text] [Related]
19. In vitro expression and characterization of MYH9 mutant alleles linked to hereditary hearing loss.
Wei CC; Lalwani AK; Mhatre AN
Otolaryngol Head Neck Surg; 2010 May; 142(5):699-703. PubMed ID: 20416459
[TBL] [Abstract][Full Text] [Related]
20. Expression of Myh9 in the mammalian cochlea: localization within the stereocilia.
Mhatre AN; Li Y; Atkin G; Maghnouj A; Lalwani AK
J Neurosci Res; 2006 Sep; 84(4):809-18. PubMed ID: 16862555
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
